Adverse Short‐Term Cardiometabolic Outcomes in Psychosis Early Intervention Services: Which Risk Prediction Algorithm?
Early Intervention in Psychiatry · 2025
DOI: 10.1111/eip.70116 ↗At a glance
Journal article in Early Intervention in Psychiatry, 2025. Written by James Hughes and 4 co-authors. Institution: Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK. Major MEDLINE topics: Psychotic Disorders, Algorithms, Early Medical Intervention, Cardiometabolic Risk Factors. 42 references. Funded by: National Institute for Health and Care Research (NIHR).
Abstract (original language)
Introduction
Weight gain and other adverse cardiometabolic changes occur early in severe mental illness (SMI) but may be preventable. It is unknown whether existing cardiometabolic risk prediction algorithms can be repurposed to predict early cardiometabolic changes after first‐episode psychosis, especially in younger populations.
Methods
Data from newly enrolled patients (16–65 years) to the Cambridgeshire and Peterborough CAMEO Early Intervention Service for Psychosis (EIS) (March 2022–Feb 2024) were used to explore the accuracy of population‐based (QRISK3, QDIABETES) and SMI‐specific (PsyMetRiC‐full, PsyMetRiC‐partial, PRIMROSE) cardiometabolic risk prediction algorithms for early cardiometabolic changes (weight, total cholesterol, triglycerides). Risk scores were calculated using baseline clinic data, and outcomes assessed at three‐monthly follow‐up. Multiple imputation was used where appropriate. Predictive accuracy was assessed using the coefficient of determination ( R 2 ) and root mean squared error (RMSE). Sensitivity analysis was conducted in younger (16–35 years) patients.
Results
We included n = 74 participants (male = 50%, white European = 75%, mean age = 32.0, median follow‐up = 112 days). Mean body weight increased by 3.58 kg, total cholesterol by 0.64 mmol/L, and triglycerides by 0.84 mmol/L. PsyMetRiC‐full was the best predictor of weight ( R 2 = 0.54, 95% C.I., 0.36–0.69, p < 0.001; RMSE = 1.91; 95% C.I., 1.58–2.37); and triglyceride changes ( R 2 = 0.36; 95% C.I. 0.12–0.56, p = 0.004; RMSE = 1.98; 95% C.I., 1.43–2.63). No algorithm accurately predicted total cholesterol changes. General population‐based algorithms performed poorly. Sensitivity analysis results were more extreme in favour of the PsyMetRiC algorithms.
Conclusion
PsyMetRiC is likely to be better than alternatives at predicting short‐term cardiometabolic changes in early psychosis, particularly in patients aged 16–35. Stakeholder engagement is now required to co‐decide ‘high‐risk’ thresholds and intervention strategies to reduce the cardiometabolic impacts of psychosis and its treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
- NHS Greater Glasgow and Clyde, Glasgow, UK.
- Department of Psychiatry, University of Cambridge, Cambridge, UK.
- Institute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
- Birmingham Early Intervention Service, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
ORCID profiles: James Hughes
Funding
- National Institute for Health and Care Research (NIHR)
Cite
APA
Hughes, J., Asok, A. M., Lim, M. F., Galindo, L., & Perry, B. I. (2025). Adverse Short‐Term Cardiometabolic Outcomes in Psychosis Early Intervention Services: Which Risk Prediction Algorithm?. Early Intervention in Psychiatry. https://doi.org/10.1111/eip.70116
Vancouver
Hughes J, Asok AM, Lim MF, Galindo L, Perry BI. Adverse Short‐Term Cardiometabolic Outcomes in Psychosis Early Intervention Services: Which Risk Prediction Algorithm?. Early Intervention in Psychiatry. 2025. doi:10.1111/eip.70116
BibTeX
@article{Hughes2025,
author = {Hughes, James and Asok, Ashwin Moothedath and Lim, Mao Fong and Galindo, Liliana and Perry, Benjamin Ian},
title = {Adverse Short‐Term Cardiometabolic Outcomes in Psychosis Early Intervention Services: Which Risk Prediction Algorithm?},
journal = {Early Intervention in Psychiatry},
year = {2025},
doi = {10.1111/eip.70116}
}
EUVIMED